指南与共识乳腺乳腺X线USMR

非典型导管增生与小叶肿瘤:指南更新与放宽

Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines.
指南 / 共识 · AJR Am J Roentgenol · 2019-12-11

本文综述空心针活检诊断为非典型导管增生、非典型小叶增生及小叶原位癌的处理证据,指出非典型导管增生仍推荐手术切除,而特定情况下非典型小叶增生和小叶原位癌可安全采用影像 surveillance。文章同时讨论这些高危病变对未来乳腺癌风险的影响及需进一步研究的方向。

要点

  • 空心针活检诊断非典型导管增生后仍推荐手术切除。
  • 特定情况下非典型小叶增生和小叶原位癌可安全采用影像 surveillance。
  • 上述高危病变诊断与未来乳腺癌风险相关。

核心结论

  • 空心针活检诊断非典型导管增生后仍推荐手术切除,但特定情况下非典型小叶增生和小叶原位癌可安全采用影像 surveillance 管理。

研究设计与样本

  • 本文为综述,综合空心针活检诊断非典型增生和小叶原位癌处理的证据,并强调需进一步研究以改进这些高危病变的实践指南。

临床应用与阅片要点

  • 空心针活检诊断为非典型导管增生时仍推荐手术切除。
  • 特定情况下非典型小叶增生和小叶原位癌可安全采用影像 surveillance 管理。

局限性

  • 原文指出需进一步研究以改进这些高危病变的实践指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. Atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), and lobular carcinoma in situ (LCIS) are among high-risk lesions that have been previously recommended for surgical excision when diagnosed on core needle biopsy. Recent studies have examined whether imaging surveillance is a reasonable alternative to surgical management for these lesions. This article synthesizes the evidence regarding management of atypical hyperplasia and LCIS diagnosed on core needle biopsy and clinical implications of these diagnoses on future breast cancer risk as well as highlights areas of further research needed to improve practice guidelines for these high-risk lesions. CONCLUSION. Although surgical excision is still recommended after diagnosis of ADH on core needle biopsy, in specific circumstances ALH and LCIS can safely be managed by imaging surveillance.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lewin AA, Mercado CL. Atypical Ductal Hyperplasia and Lobular Neoplasia: Update and Easing of Guidelines. AJR Am J Roentgenol. 2019. PMID: 31825261. doi:10.2214/AJR.19.21991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。